MicroRNAs as novel immunotherapeutics

Amy B. Heimberger*, Mark Gilbert, Ganesh Rao, Jun Wei

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


A large unmet need exists for cost-effective, widely available antineoplastic immunotherapeutic agents with a robust translational potential. MicroRNAs (miRNAs) that regulate tumor-mediated immunosuppression or immune checkpoints can induce robust therapeutic immune responses, indicating that miRNAs may ultimately become part of the portfolio of anticancer immunotherapeutics.

Original languageEnglish (US)
Article numbere25124
Issue number8
StatePublished - 2013
Externally publishedYes


  • Cancer stem cells
  • Glioblastoma multiforme
  • Immunosuppression
  • MicroRNAs
  • Regulatory T cells
  • Signal transducer and activator of transcription 3

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'MicroRNAs as novel immunotherapeutics'. Together they form a unique fingerprint.

Cite this